Immunology and Cancer Research
| Researcher | Research Focus |
|---|---|
| Prof. Barda-Saad Mira |
|
| Prof. Ben-Aroya Shay |
|
| Prof. Cohen Cyrille |
|
| Prof. Cohen Haim |
|
| Prof. Efroni Sol |
|
| Prof. Ginsberg Doron |
|
| Dr. Knisbacher Binyamin |
|
| Prof. Okun Eitan |
|
| Prof. Opatowsky Yarden |
|
| Dr. Roichman Asael |
|
| Prof. Shav-Tal Yaron |
|
| Dr. Yissachar Nissan |
|
| Prof. Emeritus Brodie Chaya |
|
| Prof. Emeritus Nir Uri |
|
| Prof. Emeritus Shredni Benjamin |
|
Prof. Mira Barda-Saad
Reprogramming the immune system to mitigate cancer and other pathologies
Why do immune cells fail within tumors, and how can we break down the physical and molecular barriers that limit immunotherapy success to improve patient outcomes?
Research Focus: Successful immune responses require coordinated signaling, cytoskeletal remodeling, and mechanical force. In cancer, these processes are disrupted, causing immune exhaustion and therapy resistance. The lab studies how mechanotransduction pathways regulate immune cell activation and dysfunction within the tumor microenvironment. By identifying molecular checkpoints that control immune mechanics, the research aims to enhance immunotherapy efficacy and guide the design of combination treatments.
Highlighted Takeaway: Targeting the mechanical control systems of immune cells offers a new therapeutic axis to improve cancer treatment.
Methods: Advanced Microscopy · Flow Cytometry · Proteomics · Tumor Immunology Models· Mechanobiology Assays · Genetic Engineering · Clinical Collaborations
Hobbies: Reading and biking
Prof. Cyrille Cohen
Cancer Immunotherapy and Immune-System Engineering
How do you truly train the immune system to fight cancer? By helping it recognize tumors precisely and persistently.
Research focus: The lab develops strategies to make immune responses stronger, more specific, and longer-lasting against cancer and viral diseases. Research includes T-cell engineering, understanding tumor immune evasion, protein design using machine learning and designing new immunotherapy approaches that connect basic immunology to clinical translation. The lab has advanced several immunotherapy treatments for multiple myeloma, amyloidosis and solid tumors into clinical stages, showing the path from academia to life-saving medicine.
Highlighted takeaway: Immunotherapy is reshaping the future of cancer treatment.
Methods: Immunology · Genetic engineering · Molecular biology · Cell culture · Animal models · Protein design · Clinical collaborations
Hobbies: Music (playing on several instruments), Street Photography, Science Fiction
Prof. Doron Ginsberg
Cell Growth, Cancer Biology and Gene Regulation
What controls the balance between cell growth and death? Cells use tightly regulated gene networks to decide whether to divide, survive, or die — and when these controls fail, cancer can take hold.
Research focus: The lab investigates the molecular mechanisms that govern cell proliferation, survival, and death, with a particular focus on the E2F family of transcription factors and long non-coding RNA transcripts (lncRNAs). Research explores how long non-coding RNA transcripts regulate genes needed for the cell cycle, how they interact with major signaling pathways, how they influence apoptosis, and how disruptions in these networks contribute to cancer development and treatment responses.
Highlighted takeaway: Understanding the effects of lncRNAs on cell fate reveals why normal growth goes awry in cancer and points to new ways to sensitize tumors to therapy.
Methods: Molecular and cellular biology · Gene regulation analysis ·Cell cycle analysis · Apoptosis assays · Signal transduction studies · Functional genomics · Cancer cell models
Hobbies: Biking and swimming
Dr. Binyamin Knisbacher
Computational Biology, Cancer Genomics and Personalized Medicine
How can a computer use big data to help a doctor choose a more precise cancer treatment? By translating genomes into decisions.
Research focus: Every cancer patient has a unique genetic story, the challenge is turning massive datasets into one actionable clinical choice. The lab integrates multi-omic sequencing data (DNA, RNA & epigenetics), clinical information and computational modeling (AI, ML & statistics) to detect patterns that explain what goes wrong in each patient and how it opens opportunities for therapy and precision medicine.
Highlighted takeaway: The future of oncology is integrating clinical and molecular data for personalized medicine - treatment plans tailored to the person.
Methods: Computational cancer genomics · Machine learning · Big data · Single-cell sequencing · Clinical data integration
Hobbies: Hiking, running and telling my kids dad jokes.
Prof. Eitan Okun
Mechanism of how Sex and Pregnancy affect Neuroimmunology and Age-related Brain Diseases
How does the immune system influence how we think, remember, and age? The brain does not work alone. It is in constant communication with the immune system, and this dialogue powerfully shapes cognition across life and during disease.
What the lab explores. The lab studies how immune activity outside the brain influences memory, aging, and vulnerability to brain disorders such as Alzheimer disease and Down syndrome, and how biological sex modulates these effects. A unique line of research investigates how pregnancy and fetal development leave lasting marks on the mother’s brain. This work shows how immune signals transferred during pregnancy can reshape brain function and affect cognition many years later, opening new possibilities for prevention. The lab views brain disease as a whole body process that connects immunity, development, and aging.
The lab utilized methods that include Cell sequencing, advanced whole-brain imaging, unique transgenic mouse models, immunology, and behavioral studies.
Hobbies: Classic rock, guitars, and everything in between.
Dr. Asael Roichman
Nutrition, Microbiome, and Metabolites in Cancer and Health
How does what we eat influence cancer? Not just calories - chemistry and microbes.
Research focus: The lab studies how diet interacts with gut bacteria to produce metabolites that affect physiology and disease. We identify bioactive food-derived molecules, track how microbes modify them, and test their effects on liver function, systemic metabolism, and cancer development. A key focus is uncovering hidden nutrition chemistry that may explain why diet influences health and treatment response.
Highlighted takeaway: Nutrition and the microbiome are central to personalized medicine. Understanding active metabolites can reshape disease prevention, diagnosis, and therapy.
Methods: High-resolution metabolomics · HPLC separations · Multi-omics · Cellular & mouse models · Gut microbiology · Advanced computational tools
Hobbies: Hiking, Music, Reading, Having good time with family and friends
Prof. Yaron Shav-Tal
RNA Biology and Cellular Dynamics
What happens to RNA from birth to death? Much more than ‘message delivery.’
Research focus: RNA is dynamic: it moves, changes, responds to the environment, and shapes cellular behavior. The lab tracks RNA life cycles, synthesis, processing, transport, export, storage, and degradation, often in real-time inside living cells. By imaging single RNA molecules, the research links RNA dynamics to stress responses, cancer, and disease.
Highlighted takeaway: Disrupted RNA dynamics are implicated in many diseases, from cancer to neurodegeneration, understanding RNA adds a deeper layer to cell biology.
Methods: Advanced fluorescence microscopy · Live-cell imaging · Biochemistry · Cell biology
Hobbies: Reading and hiking
Prof. Nissan Yissachar
Host–Microbiome Interactions and Immune Decision-Making
Can gut microbes direct immune choices? The trillions of microbes in our gut communicate with immune and nervous systems, influencing whether the body tolerates or fights inflammation, in health and disease.
Research focus: The lab investigates the cellular, molecular and genetic mechanisms that enable communication between the gut microbiome, the intestinal immune system, the enteric nervous system and the epithelium. Research aims to map how these communication networks guide immune decision-making — balancing inflammation and tolerance — in health and in autoimmune or chronic inflammatory diseases such as inflammatory bowel disease. Studies combine unique gut organ culture systems, microscopy, genomics and systems biology approaches in real time ex-vivo.
Highlighted takeaway: Gut microbiome–host cross-talk is a central regulator of immune behavior, with implications for inflammation, autoimmunity, cancer and systemic health.
Methods: Gut organ culture · High-resolution microscopy · Genomics · Molecular biology · Systems biology · Multi-omics analysis · Host–microbiome signaling assays
Hobbies: Music (classic rock, guitars…), cooking and eating!